Etiometry Honored at Pediatric Cardiac Intensive Care Society Conference
News and Press Releases
BOSTON, December 23, 2014 — Etiometry received a “Top Abstract” award at the 2014 Pediatric Cardiac Intensive Care Society (PCICS) Conference. Our abstract reported the first retrospective study of the Risk Analytics technology, and was selected out of more than 200 abstracts submitted to the conference. We would like to thank our co-authors, Dr. Melvin Almodovar from Boston Children’s Hospital, and Dr. Peter Laussen from Toronto Sick Kids Hospital.
The abstract, titled “Risk Analytics and Outcome Prediction in Neonates Following Cardiac Surgery” assessed the ability of the Risk Analytics to predict a composite poor outcome and biomarkers for inadequate oxygen delivery. The study was conducted on 274 neonates who had undergone cardiac surgery within the first 30 days of life – a population which costs the U.S. healthcare system approximately $1.4B a year, and represent some of the most difficult patients to manage in the ICU.About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
HIMSS TV: Etiometry on AI’s role in clinical decision support
In this HIMSS TV interview, Etiometry CEO Shane Cooke dives into the transformative role of AI in clinical decision support—not as a replacement for clinicians, but as a powerful tool to enhance their expertise. Watch the full interview to see how he breaks down how predictive analytics can detect patient deterioration earlier, why AI-driven insights […]
Etiometry Achieves 10th FDA Clearance for Critical Care Platform
FDA Clearance Solidifies Etiometry’s Regulatory Leadership and Cybersecurity Excellence THURSDAY, FEB. 27, 2025- Boston, MA- As cybersecurity threats in healthcare continue to rise, and with the U.S. Food and Drug Administration (FDA) implementing stricter guidelines for cybersecurity compliance, Etiometry, the leader in clinical decision support software for high-acuity units, has received its 10th FDA clearance. This […]
Etiometry Closes the Gap in ARDS/PARDS Detection
In the winter issue of Respiratory Therapy, Jo’el Barr, Clinical Development Specialist at Etiometry, shares insights on the deployment of our PARDS pathway in two top U.S. children’s hospitals. The article highlights how Etiometry’s technology is empowering clinicians to recognize and manage Pediatric ARDS more effectively, driving better outcomes for critically ill children. Read the […]